JCN Newswire Eisai and Nuvation Bio Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside the U.S., China and Japan 13 1 月, 2026 TOKYO and NEW YORK, NY., Jan 13, […]
